Skip to content

Addiction: all studies

Page 781 of 857: studies 7,801 to 7,810 of 8,563, newest first. Back to the addiction overview

Research

Examining the Effects of Meditation Techniques on Psychosocial Functioning

Research on Social Work Practice 2003 David B. Wolf, Neil Abell

Objective: An experiment was conducted to determine the effects of chanting the maha mantra on stress, depression, and the three gunas—sattva (enlightenment), rajas (passion), and tamas (inertia)—described in the Vedas as the basis of human psychology. Primary hypotheses of the study were that the maha mantra group would increase sattva and decrease stress, depression, rajas, and tamas...

Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release.

Neuropsychopharmacology 2003 Andrea Balla, Henry Sershen, Michael Serra et al.

Functional dopaminergic hyperactivity is a key feature of schizophrenia. Etiology of this dopaminergic hyperactivity, however, is unknown. We have recently demonstrated that subchronic phencyclidine (PCP) treatment in rodents induces striatal dopaminergic hyperactivity similar to that observed in schizophrenia. The present study investigates the ability of PCP to potentiate amphetamine-induced...

Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man

Journal of Psychopharmacology 2003 Torsten Passie, Matthias Karst, Mathias Borsutzky et al. 27 citations

The role of the N-methyl-D-aspartate (NMDA) neurotransmitter system in relation to psychoses is not completely understood, but represent a challenge in neurobiological research. The psychotic states induced by NMDA antagonists such as phencyclidine and ketamine have been described as being most similar to schizophrenia and the NMDA system has been implicated in the pathogenesis of...

DOI: 10.1177/0269881103017001698 (opens in new tab) Ketamine Psychotomimetic Psychopathology Psychosis +11

Effects of the 5-HT2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia

Neuropsychopharmacology 2003 Daniel Umbricht, Franz X. Vollenweider, Liselotte Schmid et al. 192 citations

Previously the NMDA (N-methyl-D-aspartate) receptor (NMDAR) antagonist ketamine was shown to disrupt generation of the auditory event-related potential (ERP) mismatch negativity (MMN) and the performance of an 'AX'-type continuous performance test (AX-CPT)--measures of auditory and visual context-dependent information processing--in a similar manner as observed in schizophrenia. This...

DOI: 10.1038/sj.npp.1300005 (opens in new tab) Full text (opens in new tab) Psilocybin Mismatch negativity Nmda receptor Schizophrenia object-oriented programming +5

Ibogaine: A Novel Anti-Addictive Compound A Comprehensive Literature Review

Maryland Shared Open Access Repository 2003 Jonathan Freedlander

Ibogaine is a naturally occurring indole alkaloid, found in a variety of African shrubsof the Tabernathe genus (Obach, Pablo, and Mash, 1998). The root of the Tabernathe ibogaplant (also known as eboga) is the most frequently cited source of ibogaine, and this plantcontains 11 other known psychoactive constituents (Popik, and Skolnick, 1999). Chemically,ibogaine is classified as a tryptamine,...

DOI: 10.13016/m2txg0-wv9p (opens in new tab) Indole alkaloid Chemical constituents Indole test Natural compound +2

The link between cannabis use and psychosis: furthering the debate

Psychological Medicine December 23, 2002 Louisa Degenhardt 34 citations

The issue of whether an association exists between cannabis and psychosis exists, and why, has received considerable attention in recent years (Hall, 1998; Mueser et al. 1998; Blanchard et al. 2000; Degenhardt & Hall, 2002). There are probably a number of reasons for the sustained interest. First, psychotic disorders such as schizophrenia are often chronic or recurring (Mason et al. 1996), are...

Probing awareness during sleep with the auditory odd-ball paradigm.

International Journal of Psychophysiology December 2002 Kimberly A Cote

During the waking state, a late component of the auditory event-related potential, P300, is elicited when subjects detect a rare 'target' stimulus. It is usually not elicited when subjects either ignore or fail to detect the stimulus. The presence of P300 is therefore thought to reflect conscious processing of the stimulus. Since P300 has been shown to be an attention-dependent cognitive...

Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively

Psychopharmacology December 1, 2002 Jordi Riba, Antoni Rodrı́guez-fornells, Manel J. Barbanoj 71 citations

RationaleAyahuasca, a South American psychotropic plant tea, combines the psychedelic agent and 5-HT(2A/2C) agonist N, N-dimethyltryptamine (DMT) with beta-carboline alkaloids showing monoamine oxidase-inhibiting properties. Current human research with psychedelics and entactogens has explored the possibility that drugs displaying agonist activity at the 5-HT(2A/2C) sites temporally disrupt...

The hallucinogen d-lysergic acid diethylamide (d-LSD) induces the immediate-early gene c-Fos in rat forebrain

Brain Research December 1, 2002 Paul S. Frankel, Kathryn A. Cunningham 41 citations

The hallucinogen d-lysergic acid diethylamide (d-LSD) evokes dramatic somatic and psychological effects. In order to analyze the neural activation induced by this unique psychoactive drug, we tested the hypothesis that expression of the immediate-early gene product c-Fos is induced in specific regions of the rat forebrain by a relatively low, behaviorally active, dose of d-LSD (0.16 mg/kg,...

Effects of smoked marijuana in healthy and HIV + marijuana smokers.

The Journal of Clinical Pharmacology November 2002 Margaret Haney

This article presents data from two avenues of marijuana research. First, the author shows that daily marijuana smoking in healthy individuals produces dependence, as demonstrated by withdrawal symptoms such as increased irritability and depression and decreased food intake. In addition, two antidepressant medications were evaluated to assess their potential effectiveness in the treatment of...